Altimmune, Inc. (ALT) Tops Q3 EPS by 6c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $5 thousand versus the consensus estimate of $2.14 thousand.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• BMO Capital Starts Cadillac Mines Corp (CADY:CN) at Outperform
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy